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Günther disease, also known as congenital erytropoietic porphyria or uroporphyrino-gen III synthase (UROS) deficiency, is a 
rare autosomal recessively inherited erytropoietic por-
phyria caused by mutation in the uroporphyrinogen 
III cosynthase gene (locus 10 q25.2-q26.3 ).1 In this 
disorder of heme biosynthesis, patients have elevated 
levels of uroporphyrin 1 and coproporphyrin 1 in the 
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erythrocytes. These porphyrin precursors are depos-
ited in many tissues, causing photosensitivity, blister-
ing and scarring of exposed areas leading to mutilating 
deformity, hypertrichosis, red urine, erytrodontia and 
retarded growth.2,3 Hemolytic anemia, splenomegaly 
and acroosteolysis may be present.4,5 Porphyrins are 
markedly increased in the bone marrow, red blood 
cells, plasma, urine and feces.
CASE 
A 1-year old male infant, born of normal consanguine-
ous parents after a full-term normal delivery, third in 
birth order, with one normal sibling and one having 
neonatal death, presented to us with bullae on the face, 
dorsa of the hands and feet, and on the scalp and ear he-
lices from nine months of age. The bullae would rupture 
after 3-4 days followed by crusting and scarring. The 
patient also had a history of failure to thrive, weakness, 
persistent lethargy, and passage of red-colored urine 
since seven months of age. General physical exami-
nation showed a weight of 8 kgs and height of 66 cm 
with severe pallor, hypertrichosis of the eyelashes and 
brownish discoloured incisor teeth (Figure 1). Systemic 
examination was normal except for hepatosplenomeg-
aly. Cutaneous examination revealed crusted ulcers, 
hypopigmented atrophic scars on scalp, forehead, dorsa 
of hands and feet (Figure 2), hyperpigmentation of the 
distal nails of both hands with onycholysis of right in-
dex finger (Figure 3). The ophthalmological examina-
tion was normal.
Laboratory investigations revealed severe anemia 
(hemoglobin, 6.4 g/dL) with anisocytosis, leucope-
nia, thrombocytopenia, prominent monocytes with no 
blasts. Bone marrow aspiration showed normoblastic 
erythroid hyperplasia with dysplasia. Liver and kidney 
function tests were normal. Ultrasound of the abdo-
men confirmed hepatosplenomegaly. A Wood’s lamp 
examination of the urine, blood and faeces showed 
bright pink fluorescence. Biochemical tests were posi-
tive for urinary, fecal, erythrocyte (Remington meth-
od) and plasma porphyrins, suggestive of congenital 
Figure 1. Brownish discoloured incisor teeth.
Figure 2. Crusted ulcers and hypopigmented scars on scalp and 
face with hypertrichosis of eyelashes.
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erythropoietic porphyria. Histopathology of the bul-
lae showed subepidermal separation with minimal in-
flammation.
DISCUSSION
The porphyrins are diseases caused by defects in heme 
biosynthesis, resulting in the accumulation and in-
creased excretion of porphyrins or porphyrin precur-
sors.1 They are classified as erythropoietic or hepatic 
depending on whether the enzyme deficiency occurs in 
red blood cells or in the liver.2 Congenital erythropoi-
etic porphyria is the most dramatic form of porphyria, 
recognised first by Gunther,3 in which the enzyme uro-
porphyrinogen III cosynthetase is deficient in the bone 
marrow. This leads to elevated levels of uroporphyrin 1 
and coprophyrin 1 in erythrocytes and urine, and cop-
roporphyrin 1 in feces.5 The clinical features include ex-
treme photosensitivity leading to erythema, edema and 
blisters on photo-exposed parts. The lesions heal over 
time with scarring, milia, and hypo- or hyperpigmenta-
tion. Repeated episodes of blistering result in mutilation 
of ears, nose and hands. As the porphyrins within the 
RBCs in the cutaneous microvasculature are exposed to 
light, haemolytic anemia can occur.4 Treatment modali-
ties include sun protection, betacarotene, intravenous 
hematin, oral activated charcoal, transfusion of eryth-
rocytes, splenectomy for intractable haemolytic anemia, 
bone marrow transplant and gene therapy.6,7 
In our patient, the history of weakness, lethargy, ane-
Figure 3. Ulcers on dorsa of hands, hyperpigmented distal nails 
and onycholysis of right index finger.
mia, failure to thrive and passage of dark red-colored 
urine was followed by photosensitivity in the form of 
vesico-bullous eruption, hypopigmentation and scarring 
at an early age. The patient had discoloured teeth with 
erythrodontia on Wood’s lamp, and positive bright pink 
fluorescence in blood, urine and feces. The patient also 
had laboratory features of haemolytic anemia. The levels 
of uroporphyrin and coprophyrin were high in RBCs and 
urine. With the above mentioned clinical, haematological 
and biochemical features, a final diagnosis of congenital 
erytropoietic porphyria was made and the patient put on 
sun protection measures and intravenous hematin.
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